Gary Bubb

Title: Innovator Gary Bubb – Pioneering Abuse Resistant Oral Dosage Forms

Introduction

Gary Bubb is an accomplished inventor based in Pittstown, NJ. With a background in pharmaceutical innovation, he has made significant contributions to the development of oral dosage forms aimed at improving safety and efficacy.

Latest Patents

Gary holds two notable patents focusing on abuse resistant oral dosage forms. His innovations include a compressed microtablet coated with a water-retardant polymer, specifically designed to prevent misuse associated with opioid medications. These oral dosage forms incorporate an opioid agonist alongside the microtablet, which may include an opioid antagonist to further enhance abuse resistance.

Career Highlights

Gary Bubb is currently associated with Elite Laboratories, Inc., where he applies his expertise in pharmaceutical formulations. His work has been instrumental in addressing the critical issues related to opioid abuse, reflecting a commitment to public health and safety through scientific advancements.

Collaborations

Within his role at Elite Laboratories, he collaborates with fellow professionals such as Christopher C. Dick and David F. Erkoboni. Their combined efforts foster an environment of innovation, driving the development of safer pharmaceuticals that meet the rigorous demands of the healthcare industry.

Conclusion

Gary Bubb stands out as a significant figure in the realm of pharmaceutical inventions. His dedication to creating abuse resistant oral dosage forms not only showcases his inventive spirit but also contributes to the ongoing efforts to combat prescription drug abuse. His work remains an essential part of advancing health and safety in medication practices.